QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results

QHSLab posts sharp revenue and margin gains but omits key financial health details.

Risk flags

• ●The absence of cash flow and detailed balance sheet disclosures makes it impossible to assess liquidity or the durability of profitability improvements. This omission is material because positive net income does not guarantee positive cash generation or financial resilience.
• ●Qualitative claims about ISP platform expansion and debt retirement are unsupported by numbers. Without figures, investors cannot gauge the scale or impact of these developments, raising concerns about selective disclosure.
• ●The company continues to report a net loss for the six-month period, despite quarterly profitability. This signals that sustained profitability is not yet established and that volatility in results remains a risk.

Bottom line

QHSLab delivers strong revenue growth, margin expansion, and a swing to quarterly profitability, all backed by clear numbers. The company’s narrative leans on realised improvements but also makes qualitative claims about platform expansion and balance sheet strength without providing supporting data. The lack of cash flow and full balance sheet details is a significant gap, leaving questions about the sustainability of these results. Investors should treat the positive trend as credible for the quarter, but not extrapolate long-term value without more comprehensive disclosures. The most important takeaway is that while operational momentum is real, the financial health of the business cannot be fully assessed from the information provided.

Announcement summary

(OTCQB: USAQ) QHSLab, Inc. reported unaudited financial results for the three and six months ended June 30, 2026, highlighting that ISP revenue increased 86.4% to $491,399 for the second quarter compared with $263,628 during the second quarter of 2025. Total revenue for the second quarter increased 40.1% to $847,490, and gross profit rose 47.8% to $589,784, with gross margin expanding to 69.6% from 65.9% in the prior-year quarter. Operating income increased to $45,245, and net income improved to $38,030 compared with a net loss of $(52,958) in the second quarter of 2025. For the first half of 2026, total revenue increased 26.0% to $1,576,175, ISP revenue increased 103.2% to $865,900, and gross profit increased 27.9% to $1,060,587. Interest expense declined 87.3% to $16,741, and net loss improved approximately 50% to $(65,876) compared with $(132,567) during the first six months of 2025. The company projects continued progress toward improved operating leverage and a highly scalable healthcare platform capable of delivering meaningful long-term value for healthcare providers and shareholders.

Disagree with this article?